🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to demonstrate superiority of rimonab...
Status
Withdrawn
Location
Sanofi-Aventis Administrative Office
Start Date
2008-09
Trial ID
NCT00754689
Treatments Being Tested
The primary objective is to show whether rimonabant reduces the risk of a h...
Status
Terminated
Location
Sanofi-Aventis Administrative Office
Start Date
2005-12
Trial ID
NCT00263042
Treatments Being Tested
The objective of the study is to evaluate the effect of Rimonabant 20mg in ...
Status
Terminated
Location
Sanofi-Aventis Administrative Office
Start Date
2006-10
Trial ID
NCT00408148
Treatments Being Tested
Primary objective: To evaluate the effect of long-term administration of R...
Status
Terminated
Location
Sanofi-Aventis
Start Date
2006-05
Trial ID
NCT00325650
Treatments Being Tested
1\) To examine the efficacy of rimonabant in decreasing weight and metaboli...
Status
Terminated
Location
Baltimore VA Medical Center
Start Date
2007-11
Trial ID
NCT00547118
Treatments Being Tested
This is a placebo controlled study comparing Rimonabant 5 mg per day for 90...
Status
Unknown
Location
Hospital Nacional de Paraplejicos
Start Date
2022-11
Trial ID
NCT05622994
Treatments Being Tested
Randomized placebo-controlled safety and feasibility study with crossover d...
Status
Completed
Location
Hospital Nacional de Paraplejicos
Start Date
2021-05-12
Trial ID
NCT05398913
Treatments Being Tested
Primary: To assess the effects of rimonabant on HbA1c in patients with Typ...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2007-10
Trial ID
NCT00546325
Treatments Being Tested
Primary : To determine the effect of Rimonabant 20 mg on changes in, HDL-C...
Status
Terminated
Location
Sanofi-Aventis Administrative Office
Start Date
2006-12
Trial ID
NCT00412698
Treatments Being Tested
The purpose of this study is to evaluate the effect of rimonabant, a cannab...
Status
Terminated
Location
New York Presbyterian Hospital-Weill Cornell Medical College
Start Date
2007-08
Trial ID
NCT00603109
Treatments Being Tested